Trevena Inc (TRVN)
1.69
-0.06
(-3.43%)
USD |
OTCM |
Nov 04, 16:00
Trevena Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
December 29, 2023 | 3.087 |
December 28, 2023 | 3.031 |
December 27, 2023 | 2.988 |
December 26, 2023 | 3.014 |
December 22, 2023 | 3.057 |
December 21, 2023 | 2.950 |
December 20, 2023 | 2.783 |
December 19, 2023 | 2.781 |
December 18, 2023 | 2.609 |
December 15, 2023 | 2.522 |
December 14, 2023 | 2.587 |
December 13, 2023 | 2.596 |
December 12, 2023 | 2.693 |
December 11, 2023 | 2.642 |
December 08, 2023 | 2.565 |
December 07, 2023 | 2.688 |
December 06, 2023 | 2.672 |
December 05, 2023 | 2.622 |
December 04, 2023 | 2.561 |
December 01, 2023 | 2.501 |
November 30, 2023 | 2.487 |
November 29, 2023 | 2.480 |
November 28, 2023 | 2.458 |
November 27, 2023 | 2.416 |
November 24, 2023 | 2.357 |
Date | Value |
---|---|
November 22, 2023 | 2.454 |
November 21, 2023 | 2.48 |
November 20, 2023 | 2.565 |
November 17, 2023 | 2.48 |
November 16, 2023 | 2.459 |
November 15, 2023 | 2.523 |
November 14, 2023 | 2.532 |
November 13, 2023 | 2.561 |
November 10, 2023 | 2.365 |
November 09, 2023 | 2.448 |
November 08, 2023 | 2.375 |
November 07, 2023 | 2.423 |
November 06, 2023 | 2.402 |
November 03, 2023 | 2.369 |
November 02, 2023 | 2.361 |
November 01, 2023 | 2.261 |
October 31, 2023 | 2.213 |
October 30, 2023 | 2.199 |
October 27, 2023 | 2.161 |
October 26, 2023 | 2.239 |
October 25, 2023 | 2.253 |
October 24, 2023 | 2.282 |
October 23, 2023 | 2.369 |
October 20, 2023 | 2.526 |
October 19, 2023 | 2.817 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3319
Minimum
Mar 24 2023
8.436
Maximum
Sep 29 2020
2.256
Average
2.017
Median
Aug 20 2021
Price to Book Value Benchmarks
Pfizer Inc | 1.790 |
United Therapeutics Corp | 2.739 |
Syndax Pharmaceuticals Inc | 3.813 |
Arcus Biosciences Inc | 2.194 |
NovaBay Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
PS Ratio | 2.760 |
Price | 1.69 |
Earnings Yield | -3.39K% |
Market Cap | 1.441M |